We are live on ! Find out more
EBS icon

Emergent Biosolutions
EBS

168 hedge funds and large institutions have $717M invested in Emergent Biosolutions in 2014 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 57 increasing their positions, 50 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 8

27% more funds holding

Funds holding: 132 → 168 (+36)

26% more capital invested

Capital invested by funds: $570M → $717M (+$148M)

14% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 50

9.04% more ownership

Funds ownership: 69.27% → 78.3% (+9%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
168
Holders Change
+36
Holders Change %
+27.27%
% of All Funds
4.85%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
44
Increased
57
Reduced
50
Closed
8
Calls
$319K
Puts
–
Net Calls
+$319K
Net Calls Change
-$278K

Top Buyers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
+$18.5M
2
NI
Numeric Investors
Massachusetts
+$10.7M
3
State Street
State Street
Massachusetts
+$10.7M
4
GT
Glenmede Trust
Pennsylvania
+$10.5M
5
GAM
Gotham Asset Management
New York
+$6.54M

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$25.1M
2
SCA
SAC Capital Advisors
Connecticut
-$12.9M
3
KCM
Kingdon Capital Management
New York
-$7.3M
4
BA
BlackRock Advisors
Delaware
-$4.75M
5
AI
Ariel Investments
Illinois
-$2.82M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
1
Bank of New York Mellon
New York
$85M +$4.59M +181,850 +6%
Vanguard Group
2
Vanguard Group
Pennsylvania
$50M +$3.4M +134,542 +7%
BC
3
Broadfin Capital
New York
$45.6M +$18.5M +731,304 +68%
BFA
4
BlackRock Fund Advisors
California
$38.8M -$3.28K -130 -0%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$32.3M +$2.38M +94,047 +8%
State Street
6
State Street
Massachusetts
$31.7M +$10.7M +423,849 +51%
BIT
7
BlackRock Institutional Trust
California
$24.8M +$403K +15,956 +2%
Loomis, Sayles & Company
8
Loomis, Sayles & Company
Massachusetts
$21.6M -$147K -5,804 -0.7%
Renaissance Technologies
9
Renaissance Technologies
New York
$19.3M +$5.03M +199,287 +35%
Invesco
10
Invesco
Georgia
$15.7M +$2.71M +107,106 +21%
NI
11
Numeric Investors
Massachusetts
$15.6M +$10.7M +425,342 +220%
UBS AM
12
UBS AM
Illinois
$15.4M -$146K -5,771 -0.9%
Fidelity Investments
13
Fidelity Investments
Massachusetts
$15.2M +$4.35M +172,137 +40%
D.E. Shaw & Co
14
D.E. Shaw & Co
New York
$11.7M -$263K -10,426 -2%
AQR Capital Management
15
AQR Capital Management
Connecticut
$11.5M -$530K -21,000 -4%
GT
16
Glenmede Trust
Pennsylvania
$10.5M +$10.5M +414,923 New
SCA
17
SAC Capital Advisors
Connecticut
$10.2M -$12.9M -511,969 -56%
Fisher Asset Management
18
Fisher Asset Management
Washington
$10.1M -$23.4K -925 -0.2%
Northern Trust
19
Northern Trust
Illinois
$9.97M -$719K -28,470 -7%
Charles Schwab
20
Charles Schwab
California
$8.16M +$2.01M +79,485 +33%
Prudential Financial
21
Prudential Financial
New Jersey
$7.95M +$2.43M +96,400 +44%
PAM
22
Panagora Asset Management
Massachusetts
$7.48M +$1.82M +72,064 +32%
Goldman Sachs
23
Goldman Sachs
New York
$7M -$548K -21,710 -7%
GAM
24
Gotham Asset Management
New York
$6.54M +$6.54M +258,760 New
Two Sigma Investments
25
Two Sigma Investments
New York
$6.1M +$3.9M +154,309 +177%
1
2 3 4 5

EBS Hedge Fund Activity: Q1 2014 in Review

168 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q1 2014, worth a combined $717M — up 26% from $570M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new EBS positions and 8 closed out — a net gain of 36 holders — while 57 added to existing stakes and 50 trimmed.

The largest buyer was Broadfin Capital, adding an estimated $18.5M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $25.1M sold.

  • 168 institutional investors held Emergent Biosolutions (EBS) as of Q1 2014, up from 132 in Q4 2013.
  • Funds reported $717M of Emergent Biosolutions stock for Q1 2014, up 26% quarter-over-quarter.
  • 44 funds opened new Emergent Biosolutions positions in Q1 2014 and 8 closed out, a net change of +36 holders.
  • The largest Emergent Biosolutions buyer in Q1 2014 was Broadfin Capital, an estimated $18.5M added.
  • The largest Emergent Biosolutions seller in Q1 2014 was Consonance Capital Management, an estimated $25.1M sold.

Based on aggregated 13F filings for Q1 2014.